Ilia Kurochkin, PhD

CRI Immuno-Informatics Fellow

Dr. Ilia Kurochkin is deciphering the regulatory networks that govern cell identity and function in order to design ways to reprogram them and improve their anti-cancer capabilities.

To that end, Dr. Kurochkin is establishing a screening platform at the single-cell level to determine whether various combinations of regulators can reprogram skin cells and induce them to become immune cells.

By labeling each immune regulator with a specific tag that enables tracking, he aims to provide a map of the regulators that can generate specific types of immune cells. Additionally, Dr. Kurochkin plans to use computational tools to analyze and identify combinations of regulators for each immune cell type.

Collectively, Dr. Kurochkin hopes his work can provide comprehensive insights into the regulatory networks underlying immune cell development and provide a toolbox to modulate the immune system. The project will open unprecedented applications of immune cells and their functions in cancer, autoimmunity, senescence, and aging.

Projects and Grants

REPROcode: A single-cell platform to define transcription factors for immune cell reprogramming

Lund University | All Cancers | 2023 | Filipe Pereira, PhD

Dot decoration
Kurochkin
Lund University (Sweden)
Postdoctoral Fellow
As a CRI Immuno-Informatics Fellow, I will study regulatory networks underlying immune cell identity and provide new tools to modulate the immune system.

You Can Help

You can help us make immunotherapy a cancer treatment option for more patients. Together, we can shift the focus from fighting cancer to overcoming cancer.